Medical supply chain risk identification and transparency enhancement
Division A — Department of Defense Authorizations › Title VII — Health Care Provisions › Subtitle C — Studies, Reports, and Other Matters
Read this section in the full bill →
This section appears in one version only, so there is nothing to compare yet.
The Secretary of Defense shall— (1) conduct a Department-wide risk assessment of the medical supply chain of the Department; (2) develop a classified, prioritized list of high-risk critical medical products for which the United States is dependent on the People’s Republic of China for precursor elements; and (3) submit to Congress a report on the findings of the assessment and mitigation strategies, including recommendations for procurement, sourcing, and domestic manufacturing actions relating to such medical products to reduce reliance on adversarial supply chains for such products.